Evaluation of the Current Opioid Misuse Measure Among Substance Use Disorder Treatment Patients

Journal of Substance Abuse Treatment

Volumn 55, Issue , 2015, Pages 15-20

  Ashrafioun, Lisham ^a,b   Bohnert, Amy S B ^b,c   Jannausch, Mary ^b,c   Ilgen, Mark A ^b,c  

^a BOWLING GREEN STATE UNIVERSITY   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Current Opioid Misuse Measure; Prescription opioids; Substance use disorder

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; ANALGESIA; ARTICLE; CURRENT OPIOID MISUSE MEASURE; DISEASE SEVERITY; DRUG DEPENDENCE TREATMENT; EVALUATION STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OPIATE ADDICTION; PAIN INTENSITY; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; ATTITUDE TO HEALTH; DRUG MISUSE; MIDDLE AGED; PROCEDURES; PSYCHOLOGICAL RATING SCALE; STANDARDS; SUBSTANCE-RELATED DISORDERS;

ADULT; ANALGESICS, OPIOID; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PRESCRIPTION DRUG MISUSE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SUBSTANCE-RELATED DISORDERS;

EID: 84930414365     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2015.02.007     Document Type: Article

References (38)

1. Aarons G.A., Brown S.A., Stice E., Coe M.T. Psychometric evaluation of the marijuana and stimulant effect expectancy questionnaires for adolescents. Addictive Behaviors 2001, 26:219-236. 10.1016/S0306-4603(00)00103-9.
2. Bohnert A.S.B., Eisenberg A., Whiteside L., Price A., McCabe E., Ilgen M.A. Prescription opioid use among addictions treatment patients: Nonmedical use for pain relief vs. other forms of nonmedical use. Addictive Behaviors 2013, 38:1776-1781. 10.1016/j.addbeh.2012.11.0056.
3. Bohnert A.S.B., Valenstein M., Bair M.J., Ganoczy D., McCarthy J.F., Ilgen M.A., et al. Association between opioid prescribing patterns and opioid overdose-related deaths. Journal of the American Medical Association 2011, 305:1315. 10.1001/jama.2011.370.
4. Boyd C.J., McCabe S.E., Cranford J.A., Young A. Adolescents' motivations to abuse prescription medications. Pediatrics 2006, 118:2472-2480. 10.1542/peds. 2006-1644.
5. Butler S.F., Budman S.H., Fanciullo G.J., Jamison R.N. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clinical Journal of Pain 2010, 26:770-776. 10.1097/AJP.0b013e3181f195ba.
6. Butler S.F., Budman S.H., Fernandez K.C., Houle B., Benoit C., Katz N., et al. Development and validation of the Current Opioid Misuse Measure. Pain 2007, 130:144-156. 10.1016/j.pain.2007.01.014.
7. Butler S.F., Villapiano A., Malinow A. The effect of computer-mediated administration on self-disclosure of problems on the Addiction Severity Index. Journal of Addiction Medicine 2009, 3:194-203. 10.1097/ADM.0b013e3181902844.
8. Clark L.A., Watson W. Constructing validity: Basic issues on objective scale development. Psychological Assessment 1995, 7:309-319.
9. Compton W.M., Volkow N.D. Abuse of prescription drugs and the risk of addiction. Drug & Alcohol Dependence 2006, 83:S4-S7. 10.1016/j.drugalcdep.2005.10.020.
10. Comrey A.L., Lee H.B. A first course in factor analysis 1992, Psychology Press, New York, NY. 2nd ed.
11. Edlund M.J., Steffick D., Hudson T., Harris K.M., Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007, 129:355-362. 10.1016/j.pain.2007.02.014.
12. Farrar J.T., Young J.P., LaMoreaux L., Werth J.L., Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001, 94:149-158.
13. Galen L.W., Henderson M.J. Validation of cocaine and marijuana effect expectancies in a treatment setting. Addictive Behaviors 1999, 24:719-724. 10.1016/S0306-4603(98)00110-5.
14. Governale L. Outpatient prescription opioid utilization in the US, years 2000-2009 2010, Food and Drug Administration, Division of Epidemiology.
15. Ilgen M.A., Haas E., Czyz E., Webster L., Sorrell J.T., Chermack S. Treating chronic pain in veterans presenting to an addictions treatment program. Cognitive & Behavioral Practice 2011, 18:149-160. (j.cbpra.2010.05.002).
16. Ilgen M.A., Roeder K.M., Webster L., Mowbray O.P., Perron B.E., Chermack S.T., et al. Measuring pain medication expectancies in adults treated for substance use disorders. Drug & Alcohol Dependence 2011, 115:51-56. 10.1016/j.drugalcdep.2010.10.007.
17. Ives T.J., Chelminski P.R., Hammett-Stabler C.A., Malone R.M., Perhac J.S., Potisek N.M., et al. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Services Research 2006, 6:46. 10.1186/1472-6963-6-46.
18. Jones C.M., Mack K.A., Paulozzi L.J. Pharmaceutical overdose deaths, United States. (2010). Journal of the American Medical Association 2013, 309:657-659. 10.1001/jama.2013.272.
19. Kilbey M.M., Downey K., Breslau N. Predicting the emergence and persistence of alcohol dependence in young adults: The role of expectancy and other risk factors. Experimenta & Clinical Psychopharmacology 1998, 6:149-156. 10.1037/1064-1297.6.2.149.
20. Leider H.L., Dhaliwal J., Davis E.J., Kulakodlu M., Buikema A.R. Healthcare costs and nonadherence among chronic opioid users. American Journal of Managed Care 2011, 17:32-40.
21. Leonhard C., Mulvey K., Gastfriend D.R., Shwartz M. The Addiction Severity Index: A field study of internal consistency and validity. Jounral of Substance Abuse Treatment 2000, 18:129-135. 10.1016/S0740-5472(99)00025-2.
22. Liebschutz J.M., Saitz R., Weiss R.D., Averbuch T., Schwartz S., Meltzer E.C., et al. Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. Journal of Pain 2010, 11:1047-1055. 10.1016/j.jpain.2009.10.012.
23. Lusted A., Roerecke M., Goldner E., Rehm J., Fischer B. Prevalence of pain among nonmedical prescription opioid users in substance use treatment populations: Systematic review and meta-analyses. Pain Physician 2013, 16:E671-E684.
24. MacCallum R.C., Zhang S., Preacher K.J., Rucker D.D. On the practice of dichotomization of quantitative variables. Psychological Methods 2002, 7:19-40. 10.1037//1082-989X.7.1.19.
25. McLellan A.T., Luborsky L., Woody G.E., O'Brien C.P. An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous & Mental Disease 1980, 168:26-33. 10.1097/00005053-198001000-00006.
26. Meltzer E.C., Rybin D., Saitz R., Samet J.H., Schwartz S.L., Butler S.F., et al. Identifying prescription opioid use disorder in primary care: Diagnostic characteristics of the Current Opioid Misuse Measure (COMM). Pain 2011, 152:397-402. 10.1016/j.pain.2010.11.006.
27. Michna E., Ross E.L., Hynes W.L., Nedeljkovic S.S., Soumekh S., Janfaza D., et al. Predicting aberrant drug behavior in patients treated for chronic pain: Importance of abuse history. Journal of Pain & Symptom Management 2004, 28:250-258. 10.1016/j.jpainsymman.2004.04.007.
28. Olfson M., Wang S., Iza M., Crystal S., Blanco C. National trends in the office based prescription of schedule II opioids. Journal of Clinical Psychiatry 2013, 74:932-939. 10.4088/JCP.13m08349.
29. Paulozzi L.J., Kilbourne E.M., Desai H.A. Prescription drug monitoring programs and death rates from drug overdose. Pain Medicine 2011, 12:747-754. 10.1111/j.1526-4637.2011.01062.x.
30. Price A.M., Ilgen M.A., Bohnert A.S.B. Prevalence and correlates of nonmedical use of prescription opioids in patients seen in a residential drug and alcohol treatment program. Journal of Substance Abuse Treatment 2011, 41:208-214. 10.1016/j.jsat.2011.02.003.
31. Rosenblum A., Joseph H., Fong C., Kipnis S., Cleland C., Portenoy R.K. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. Journal of the American Medical Association 2003, 289:2370. 10.1001/jama.289.18.2370.
32. Schafer J., Brown S.A. Marijuana and cocaine effect expectancies and drug use patterns. Journal of Consulting & Clinical Psychology 1991, 59:558-565. 10.1037/0022-006X.59.4.558.
33. Schieffer B.M., Pham Q., Labus J., Baria A., Van Vort W., Davis P., et al. Pain medication beliefs and medication misuse in chronic pain. Journal of Pain 2005, 6:620-629. 10.1016/j.jpain.2005.04.004.
34. Sher K.J., Wood M.D., Wood P.K., Raskin G. Alcohol outcome expectancies and alcohol use: A latent variable cross-lagged panel study. Journal of Abnormal Psychology 1996, 105:561-574. 10.1037/0021-843X.105.4.561.
35. Substance Abuse and Mental Health Services Administration Drug Abuse Warning Network, 2011: National estimates of drug-related emergency department visits. HHS publication no. (SMA) 13-4760, DAWN series D-39 2013, Substance Abuse and Mental Health Services Administration, Rockville, MD.
36. Substance Abuse and Mental Health Services Administration Results from the 2012 National Survey on Drug Use and Health: Mental health findings 2013, Substance Abuse and Mental Health Services Administration, NSDUH Series H-47, HHS Publication No. (SMA) 13-4805, Rockville, MD.
37. Trafton J.A., Oliva E.M., Horst D.A., Minkel J.D., Humphreys K. Treatment needs associated with pain in substance use disorder patients: Implications for concurrent treatment. Drug & Alcohol Dependence 2004, 73:23-31. 10.1016/j.drugalcdep.2003.08.007.
38. Ware J., Kosinski M., Keller S.D. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care 1996, 34:220-233. 10.1097/00005650-199603000-00003.